Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src
- 14 January 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (4) , 871-887
- https://doi.org/10.1021/jm030317k
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signallingNature Cell Biology, 2002
- Src kinase contributes to the metastatic spread of carcinoma cellsOncogene, 2002
- Activation of Src kinase in primary colorectal carcinomaCancer, 2002
- Deregulation of the Cytoplasmic Tyrosine Kinase cSrc in the Absence of a Truncating Mutation at Codon 531 in Human Bladder CarcinomaBiochemical and Biophysical Research Communications, 2000
- N-Substituted (2,3-Dihydro-1,4-benzodioxin-2-yl)methylamine Derivatives as D2 Antagonists/5-HT1A Partial Agonists with Potential as Atypical Antipsychotic AgentsJournal of Medicinal Chemistry, 1999
- Crystal structure of the Src family tyrosine kinase HckNature, 1997
- Validation of the general purpose QUANTA ®3.2/CHARMm® force fieldJournal of Computational Chemistry, 1992
- Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.Annals of the Rheumatic Diseases, 1989
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983
- Furan and Tetrahydrofuran Derivatives. III. The Synthesis of Certain 3,4-Diaminofuran Derivatives1Journal of the American Chemical Society, 1945